NEW YORK, NY--(Marketwire - Feb 8, 2013) - Health Care stocks have been on an impressive run to start 2013. The Affordable Care Act will provide millions of Americans with access to healthcare, creating new revenue streams for companies across the sector. Research Driven Investing examines investing opportunities in the Health Care Sector and provides equity research on CIGNA Corporation (NYSE: CI) and Express Scripts Holding Company (NASDAQ: ESRX).
Access to the full company reports can be found at:
The Affordable Care Act (Obamacare) requires every American to acquire health insurance by 2014 or be subjected to a tax. For those who can't afford health insurance they will be offered subsidies or Medicaid. Statistics from the Census Bureau show that approximately 50 million Americans did not have health insurance in 2009.
According to the Centers for Medicare and Medicaid Services total health care spending is projected to grow from an estimated $2.8 trillion last year to $4.8 trillion by 2021, an increase of 70 percent. "There's just a lot more money flowing into health care and we're seeing the markets react accordingly," says Invesco portfolio manager, Derek Taner.
Research Driven Investing releases regular market updates on the Health Care Sector so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and industry newsletters.
Cigna maintains sales capability in 30 countries and jurisdictions, and has approximately 75 million customer relationships throughout the world. Shares of the company spiked Thursday after reporting a net income of $406 million in the fourth quarter, an increase of 49 percent when compared to the year ago period. The company's strong growth in earnings was largely due to their acquisition of HealthSpring.
Express Scripts provides a range of pharmacy benefit management (PBM) services in North America. The company manages more than a billion prescriptions each year for tens of millions of people. The company is scheduled to release results for the fourth quarter after market close on Monday, February 18th.
Research Driven Investing has not been compensated by any of the above-mentioned publicly traded companies. Paragon Report is compensated by other third party organizations for advertising services. We act as an independent research portal and are aware that all investment entails inherent risks. Please view the full disclaimer at: